Smith+Nephew announces it has signed an exclusive U.S. distribution agreement with RMR Ortho to add the A’TOMIC Nitinol Fixation System to the Smith+Nephew Trauma, Foot & Ankle and Hand & Wrist portfolio. “This partnership with RMR Ortho strengthens Smith+Nephew’s fixation portfolio by adding a dynamic compression fixation solution that complements our existing technologies,” said Scott Gunn, Vice President of U.S. Marketing, Trauma, Extremities, and Shoulder at Smith+Nephew. “The A’TOMIC Nitinol Fixation System expands our ability to participate in high-frequency fracture and arthrodesis procedures while leveraging our established Extremities and Trauma sales channel to deepen surgeon engagement. This collaboration reflects our disciplined approach to portfolio expansion and our continued focus on driving sustainable growth.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNN:
- Smith & Nephew signs distribution agreement with SI-Bone
- Smith+Nephew Sets 2 March 2026 Date for 2025 Full-Year Results
- Smith & Nephew Reports Routine Six-Month Update on Employee Share Schemes
- Smith & Nephew Updates Share Capital and Voting Rights as of 31 January 2026
- Smith & Nephew: Underappreciated Sports Medicine Growth Platforms Support Re‑Rating Potential and Justify Buy Rating
